Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUT FLEMMING JAKOBSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.2% 1.5% 1.3% 1.3% 1.3% 3.4% 7.4% 7.4%   Credit score (0-100)   68 78 79 79 79 53 33 33   Credit rating   BBB A A A A BBB BB BB   Credit limit (kDKK)   0.1 10.3 21.4 29.5 23.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   829 925 944 1,051 1,056 1,133 0.0 0.0   EBITDA   195 311 358 448 448 541 0.0 0.0   EBIT   130 248 301 396 396 495 0.0 0.0   Pre-tax profit (PTP)   49.2 248.7 255.9 477.0 281.4 412.4 0.0 0.0   Net earnings   38.0 193.6 199.2 371.8 219.1 321.5 0.0 0.0   Pre-tax profit without non-rec. items   49.2 249 256 477 281 412 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   52.1 32.9 19.5 11.1 2.7 0.0 0.0 0.0   Shareholders equity total   1,102 1,185 1,194 1,376 1,225 1,337 892 892   Interest-bearing liabilities   281 340 336 418 656 812 0.0 0.0   Balance sheet total (assets)   1,606 1,764 1,910 2,177 2,189 5,383 892 892   Net Debt   -753 -892 -1,077 -1,321 -1,158 -4,168 -706 -706     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   829 925 944 1,051 1,056 1,133 0.0 0.0   Gross profit growth   -4.6% 11.6% 2.0% 11.4% 0.5% 7.3% -100.0% 0.0%   Employees   2 2 1 1 1 1 0 0   Employee growth %   0.0% 0.0% -50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,606 1,764 1,910 2,177 2,189 5,383 892 892   Balance sheet change%   -3.8% 9.8% 8.3% 13.9% 0.6% 145.9% -83.4% 0.0%   Added value   195.3 311.2 358.5 447.6 448.3 541.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -130 -126 -114 -104 -104 -93 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.7% 26.8% 31.9% 37.6% 37.5% 43.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.8% 15.5% 16.4% 24.2% 18.2% 13.1% 0.0% 0.0%   ROI %   9.8% 16.9% 18.8% 28.7% 20.9% 24.0% 0.0% 0.0%   ROE %   3.3% 16.9% 16.7% 28.9% 16.8% 25.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   68.6% 67.2% 62.5% 63.2% 56.0% 24.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -385.6% -286.5% -300.5% -295.2% -258.4% -769.9% 0.0% 0.0%   Gearing %   25.5% 28.7% 28.1% 30.4% 53.5% 60.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   39.9% 3.8% 13.4% 4.9% 21.4% 11.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   3.0 3.2 2.7 3.0 2.3 1.3 0.0 0.0   Current Ratio   3.0 3.2 2.7 3.0 2.3 1.3 0.0 0.0   Cash and cash equivalent   1,033.5 1,231.9 1,413.2 1,739.1 1,814.3 4,980.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   654.2 821.1 110.5 282.0 -281.9 1,035.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   98 156 358 448 448 541 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   98 156 358 448 448 541 0 0   EBIT / employee   65 124 301 396 396 495 0 0   Net earnings / employee   19 97 199 372 219 321 0 0